Chronic heart failure.
Poole-Wilson
Philip A
PA
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D047228:Angiotensin II Type 1 Receptor Blockers / Q000627:therapeutic use; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D001341:Autonomic Nervous System / Q000503:physiopathology; D002908:Chronic Disease; D004232:Diuretics / Q000627:therapeutic use; D014943:Global Health; D006333:Heart Failure / Q000175:diagnosis / Q000276:immunology / Q000503:physiopathology / Q000628:therapy*; D006801:Humans; D008955:Models, Cardiovascular; D017410:Practice Guidelines as Topic; D018570:Risk Assessment; D033581:Stem Cell Transplantation
D000319:Adrenergic beta-Antagonists; D047228:Angiotensin II Type 1 Receptor Blockers; D000806:Angiotensin-Converting Enzyme Inhibitors; D004232:Diuretics